Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frankel

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancersV Chung, F J Kos, N Hardwick, et al.
Oncogene|September 1, 1999
RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteasesJ A Aguirre-Ghiso, P Frankel, E F Farias, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Functional association between Arf and RalA in active phospholipase D complexJ Q Luo, X Liu, P Frankel, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2011
A phase I study of bortezomib and temozolomide in patients with advanced solid tumorsJ Portnow, P Frankel, S Koehler, et al.
British Journal of Cancer|August 15, 2002
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerG Somlo, J F Simpson, P Frankel, et al.
Breast Cancer Research and Treatment|November 2, 2011
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancerG Somlo, C L Martel, S K Lau, et al.
Leukemia|June 1, 2011
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaM H Kirschbaum, T Synold, A S Stein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2012
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancerA VanderWalde, W Ye, P Frankel, et al.
Journal of the Neurological Sciences|February 17, 2000
The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosisB Sharrack, R A Hughes, R W Morris, et al.
Bone Marrow Transplantation|March 28, 2006
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myelomaF Sahebi, R Spielberger, N M Kogut, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancersV Chung, F J Kos, N Hardwick, et al.
Oncogene|September 1, 1999
RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteasesJ A Aguirre-Ghiso, P Frankel, E F Farias, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Functional association between Arf and RalA in active phospholipase D complexJ Q Luo, X Liu, P Frankel, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2011
A phase I study of bortezomib and temozolomide in patients with advanced solid tumorsJ Portnow, P Frankel, S Koehler, et al.
British Journal of Cancer|August 15, 2002
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerG Somlo, J F Simpson, P Frankel, et al.
Breast Cancer Research and Treatment|November 2, 2011
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancerG Somlo, C L Martel, S K Lau, et al.
Leukemia|June 1, 2011
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaM H Kirschbaum, T Synold, A S Stein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2012
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancerA VanderWalde, W Ye, P Frankel, et al.
Journal of the Neurological Sciences|February 17, 2000
The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosisB Sharrack, R A Hughes, R W Morris, et al.
Bone Marrow Transplantation|March 28, 2006
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myelomaF Sahebi, R Spielberger, N M Kogut, et al.
Pageof 8